Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study.
about
Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi.Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma.Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study.Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients.Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphomaClinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component.Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphomaThe role of transplantation in diffuse large B-cell lymphoma: the impact of rituximab plus chemotherapy in first-line and relapsed settings.Lenalidomide in diffuse large B-cell lymphomas.The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma.A Review of Autologous Stem Cell Transplantation in Lymphoma.The role of autologous stem cell transplantation in the treatment of diffuse large B-cell lymphoma.Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCTDetailed analysis of diffuse large B cell lymphoma patients: a single-center, retrospective studyAutologous stem cell transplantation for aggressive lymphomas.First-line therapy of CD20+ diffuse large B-cell lymphoma: facts and open questions.Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial.Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma.
P2860
Q33408772-9F594782-2FC8-49F4-A365-477C6F87D806Q33413210-FC1F944A-231A-4FF6-9900-C66D56622182Q35143471-405D55E5-4254-462A-ADB0-F45408D24C10Q36416332-36EAB364-E5B9-4B1F-939F-C8C12E92E31CQ37548821-C239484D-6483-4D2F-B2E2-8331D8B6D3BDQ37613310-62FDD3FD-9C39-4A10-8808-01C605C69780Q37685724-2DC3965B-20D9-463F-AD4F-746F560EDEFFQ37700942-9B8B808A-35FA-42FB-8AC4-7E6FC32A13DAQ37824456-12DE73F8-EF41-4AD7-AD2D-BA6A966E5224Q38026039-6C2D1821-22EE-47F1-AAA2-C4F7D79BE0A5Q38190105-FFC58565-9095-4222-B8BD-9D1604F7A9F1Q39288544-452719E2-E5BD-4337-9985-013EFB2C7250Q40795258-19455DFC-337E-40D1-A0A5-61E216CE443BQ40797419-F25D322A-601B-4655-BA2D-8B080A272517Q42104119-CAA71617-3248-4962-8A76-A2291A96DFCBQ42357660-C288181B-8B12-4BBD-8E3D-A245875AC4F3Q42547376-8B0D53BC-DD62-4D34-AF10-3E5228F01EE5Q43607225-EFFDC0C5-DB62-47BA-B5C3-0FF65D4832FEQ43930995-0850173E-26D5-46F3-AB33-4F77E17C5AA1Q49139763-ECAA6113-77D9-4B22-9AE7-58F5E40B8962
P2860
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dose-dense and high-dose chemo ...... a phase II multicenter study.
@en
Dose-dense and high-dose chemo ...... a phase II multicenter study.
@nl
type
label
Dose-dense and high-dose chemo ...... a phase II multicenter study.
@en
Dose-dense and high-dose chemo ...... a phase II multicenter study.
@nl
prefLabel
Dose-dense and high-dose chemo ...... a phase II multicenter study.
@en
Dose-dense and high-dose chemo ...... a phase II multicenter study.
@nl
P2093
P2860
P50
P1433
P1476
Dose-dense and high-dose chemo ...... a phase II multicenter study.
@en
P2093
Alessandra Tucci
Alessandro Levis
Anna Marina Liberati
Anna Tonso
Barbara Botto
Delia Rota-Scalabrini
Domenico Novero
Enrico Pogliani
Flavia Salvi
Gruppo Italiano Multiregionale Linfomi e Leucemie (GIMURELL)
P2860
P304
P356
10.3324/HAEMATOL.2009.007005
P50
P577
2009-07-07T00:00:00Z